okilactomycin: from actinomycetes strain YP-02908L; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 10477012 |
| MeSH ID | M0153791 |
| Synonym |
|---|
| okilactomycin |
| 3,5-ethano-2h-furo(2,3-o)(2)benzoxacycloundecin-13-carboxylic acid, 3,3a,5,6,7,8,9,10,11,11a,14,15-dodecahydro-2,17-dioxo-16-methylene-3,6,8,14-tetramethyl-, (3r-(3r*,3ar*,5r*,6r*,8r*,11as*,14s*,15as*))- |
| HY-127007 |
| CS-0091152 |
| (1s,3s,6s,10r,12r,13r,16r,19r)-3,10,12,16-tetramethyl-14-methylidene-15,17-dioxo-18,20-dioxatetracyclo[11.5.2.01,6.016,19]icos-4-ene-4-carboxylic acid |
| Excerpt | Reference | Relevance |
|---|---|---|
| "Okilactomycin has a unique structure containing 13-membered ring cyclized by carbon-carbon bond." | ( Okilactomycin, a novel antibiotic produced by a Streptomyces species. II. Structure determination. Fujita, S; Furuya, T; Imai, H; Kaniwa, H; Matsumoto, H; Shimizu, M; Tokunaga, T, 1987) | 2.44 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||